(Q51563530)

English

Fructose and glucose combined with free fatty acids induce metabolic disorders in HepG2 cell: A new model to study the impacts of high-fructose/sucrose and high-fat diets in vitro.

scientific article published on 13 January 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

Fructose and glucose combined with free fatty acids induce metabolic disorders in HepG2 cell: A new model to study the impacts of high-fructose/sucrose and high-fat diets in vitro. (English)

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

author name string

Liang Zhao

1

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

Xiaoxuan Guo

2

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

Ou Wang

3

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

Hongjuan Zhang

4

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

Yong Wang

5

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

Feng Zhou

6

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

Jia Liu

7

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

Baoping Ji

8

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

publication date

13 January 2016

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

Molecular Nutrition and Food Research

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

60

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

909-921

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

4

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

Metabolic effects of fructose and the worldwide increase in obesity.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Nutritively sweetened beverage consumption and body weight: a systematic review and meta-analysis of randomized experiments

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Sugar-Sweetened Beverage Intake Trends in US Adolescents and Their Association with Insulin Resistance-Related Parameters

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Fructose and metabolic diseases: new findings, new questions

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Total fructose intake and risk of hypertension: a systematic review and meta-analysis of prospective cohorts

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Replacing dietary glucose with fructose increases ChREBP activity and SREBP-1 protein in rat liver nucleus

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Effect of troxerutin on insulin signaling molecules in the gastrocnemius muscle of high fat and sucrose-induced type-2 diabetic adult male rat.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Effects of fructose and/or fat in the diet on developing the type 2 diabetic-like syndrome in CD-1 mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

The role of fructose transporters in diseases linked to excessive fructose intake

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Fructose impairs glucose-induced hepatic triglyceride synthesis

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Direct spectrophotometric determination of serum fructose in pancreatic cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Comparative effects of fructose and glucose on lipogenic gene expression and intermediary metabolism in HepG2 liver cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

A human hepatocellular in vitro model to investigate steatosis.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Anthocyanins-rich extract of wild Chinese blueberry protects glucolipotoxicity-induced INS832/13 β-cell against dysfunction and death

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

A diet formula of Puerariae radix, Lycium barbarum, Crataegus pinnatifida, and Polygonati rhizoma alleviates insulin resistance and hepatic steatosis in CD-1 mice and HepG2 cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Triterpenoid saponins from Stauntonia chinensis ameliorate insulin resistance via the AMP-activated protein kinase and IR/IRS-1/PI3K/Akt pathways in insulin-resistant HepG2 cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Calebin-A inhibits adipogenesis and hepatic steatosis in high-fat diet-induced obesity via activation of AMPK signaling

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Fructose consumption: recent results and their potential implications

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Troxerutin protects against high cholesterol-induced cognitive deficits in mice.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Aspalathin improves glucose and lipid metabolism in 3T3-L1 adipocytes exposed to palmitate

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Fucoidan, a sulfated polysaccharide, inhibits adipogenesis through the mitogen-activated protein kinase pathway in 3T3-L1 preadipocytes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500635

21 January 2018

Identifiers

10.1002/MNFR.201500635

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/26763130

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51563530&oldid=782245617"